Slimmed down Intercell hopes to be profitable in 2014

Intercell AG of said in its preliminary annual report for 2011 that restructuring should lead to profitability in 2014. The Austrian vaccine producer reported a €29.3 million loss for 2011, much lower than the €255.2 million deficit in 2010.